Two pivotal Phase 3 trials of Haduvio are expected to launch this year and, if positive, may support applications seeking its ...

Conference call and webcast to be held at 4:30 p.m. ETNEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics ...

New research suggests millions taking GLP-1 weight-loss injections could also face a greater risk of developing a chronic cough.

Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing ...

NorthStrive Fund II LP ("NorthStrive Fund", "we", "our" or "us"), a subsidiary of NorthStrive Companies Inc., headquartered in Newport Beach, California, is a significant shareholder of Bluejay ...

Fireside chat with management on February 25, 2026, at 9:20 a.m. ETNEW HAVEN, Conn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Trevi ...

Costa Mesa, California - March 06, 2026 - PRESSADVANTAGE - Sneezing or coughing in cats can quickly raise concern among ...

A leaked Kremlin video showing Russian President Vladimir Putin coughing and pausing during a meeting has sparked fresh speculation about his health online. While the clip quickly went viral, experts ...

The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic cough ...

The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic cough First pivotal trial is on track to initiate in the second quarter of ...